ArticleCase reports in rheumatology2018
A Case of Atorvastatin-Associated Necrotizing Autoimmune Myopathy, Mimicking Idiopathic Polymyositis.
Article in Case reports in rheumatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Article
- Unveiling the Rare Complication: Statin-Induced Immune-Mediated Necrotizing Myopathy.The American journal of case reports · 2023Article
- Statin-induced necrotizing autoimmune myopathy: a systematic review.Reumatologia · 2022Review
- Rituximab use for refractory anti-HMGCR immune-mediated necrotizing myopathy: A case report.Intractable & rare diseases research · 2021Article
- Statin-induced necrotizing autoimmune myopathy.Proceedings (Baylor University. Medical Center) · 2020Article
- Article
- Statin-induced necrotising autoimmune myopathy and autoimmune hepatitis presenting with dysphagia.BMJ case reports · 2020Article
- Anti-HMGCR myopathy presenting with acute systolic heart failure.BMJ case reports · 2019Article
- [Interaction between atorvastatin and voriconazole in rat plasma: a HPLC-MS/MS-based study].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019Article
- A RARE CASE OF STATIN-INDUCED NECROTIZING AUTOIMMUNE MYOPATHY.AACE clinical case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Statin-induced necrotizing autoimmune myopathy (SINAM) is a rare side effect of statin use which manifests as progressive muscle weakness. Because statins are a widely prescribed medication for coronary artery disease, hyperlipidemia, and many other diseases, many patients are at risk of developing SINAM or one of the many other statin-induced myopathies. Due to identification of an antibody specific to this disease, we were able to diagnose SINAM in a patient whose symptoms had progressed to the extent that they were debilitating. Our case describes SINAM in a patient undergoing treatment with a statin for an extended period of time, diagnosis of the disease process, treatment, and resolution of symptoms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.